Prima-Temp Named Venture+ Forum Pitch Competition Winner At 2014 mHealth Summit

 

WASHINGTON, Jan. 6, 2015-- The mHealth Summit announced today that Prima-Temp, Inc., was named the winner of its 2014 Venture+ Forum mHealth Pitch competition for startups. Twenty-one startup companies were selected to deliver live pitch presentations to a panel of investors and leaders from digital health accelerators, as part of the mHealth Summit's Venture+ Forum held last month. Prima-Temp is creating wireless, continuous temperature monitoring to address a variety of physiological needs, including a new fertility awareness sensor.

The 2014 Presenting Companies were selected based on criteria for demonstrated impact and quantifiable results for improving health care delivery and outcomes.  The Venture+ Forum is designed to provide an important platform for health entrepreneurs to foster cutting-edge collaborations and support the adoption of innovative, evidence-based and outcomes-driven digital health technology solutions.  

"Supporting innovation and early-stage development is a vital component to feeding a successful mobile and connected health ecosystem. Programs like Venture+ Forum and our Startup Showcase at the mHealth Summit are designed to address the specific needs of entrepreneurs and early-stage companies, and create unique partnering opportunities with serious dealmakers," said Richard Scarfo, Director, mHealth Summit, and Vice President, Personal Connected Health Alliance. "Congratulations to Prima-Temp, as well as the other companies that participated in the competition."

Prima-Temp's first product, BLOOM, is a wearable device to continuously track a woman's core body temperature, sending an alert to her smartphone when she's most fertile. Other products in development include wireless, continuous temperature sensing for early infection detection, organ rejection, heat stroke, sleep disorders and weight loss. The company will be a featured presenter at the 2015 mHealth Summit, and have a complimentary kiosk at the new HX360 event and Venture+ Forum taking place at HIMSS15 Annual Conference, April 12-16, 2015.

About the mHealth Summit
The mHealth Summit is the global convener of the expanding mobile health ecosystem, exploring the disruptions, challenges and opportunities of the integration of mobile and wireless technologies into the healthcare system, and in consumer and patient engagement, for the delivery of better health outcomes. The 7th Annual mHealth Summit will take place November 8-11, 2015, in Washington, D.C. Focusing on four fundamental platforms – technology, business, research and policy – the mHealth Summit is presented by HIMSS, in partnership with Continua, the Foundation for the NIH and the mHealth Working Group. mHealth Summit is part of the Personal Connected Health Alliance (PCHA), an international non-profit organization established by Continua, mHealth Summit and HIMSS to represent the consumer voice in personal connected health. Visit the mHealth Summit for more information; and follow at @mhealthsummit.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.